Carbylan Therapeutics Announces Decision to Pursue Strategic Transaction
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
JMP Securities Downgrades Carbylan Therapeutics (CBYL) to Market Perform
April 18, 2016 8:13 AM EDTJMP Securities downgraded Carbylan Therapeutics (NASDAQ: CBYL) from Market Outperform to Market Perform.
For an analyst ratings summary and ratings history on Carbylan Therapeutics click here. For more ratings news on Carbylan Therapeutics click here.
Shares of Carbylan Therapeutics closed at $0.64 yesterday.
... More